Evidence map›Paper›PMID 23922396›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance.

Kira Rubtsova, Anatoly V Rubtsov, Linda F van Dyk, John W Kappler, Philippa Marrack

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 200 papers.

0numbers the graph read from it
0cells of the map it votes in
200citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

200 citing papers in PubMed, 304 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Molecular Insights into Oral Manifestations in Sjögren's Disease.International journal of molecular sciences · 2026
    Review
  10. Review
  11. Review
  12. Article
  13. ODC1 restricts meningeal B cell age-associated-like phenotype and function in multiple sclerosis: A human and experimental study.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  14. Article
  15. Article
  16. The multilayered identity of B cell memory.Cellular & molecular immunology · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Review

140 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Kira RubtsovaHoward Hughes Medical Institute, Denver, CO 80206, USA.
Anatoly V Rubtsov
Linda F van Dyk
John W Kappler
Philippa Marrack
National Jewish Health · USHoward Hughes Medical Institute · USUniversity of Colorado Denver · US

Funding

THE REGULATION OF V ALPHA 7 EXPRESSING T CELLSP01AI022295 · NIAID · NATIONAL JEWISH HEALTH · PI REFAELI, YOSEF · 1985 to 2011
$11.7M
CHARACTERISTICS OF T CELL RECEPTORSR01AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1985 to 2022
$7.3M
Molecular Mechanisms of Immune ToleranceT32AI074491 · NIAID · NATIONAL JEWISH HEALTH · PI CAMBIER, JOHN C, PELANDA, ROBERTA · 2009 to 2023
$4.1M
Cyclin requirements in gammaherpesvirus infection and diseaseR01CA168558 · NCI · UNIVERSITY OF COLORADO DENVER · PI VAN DYK, LINDA F. · 2012 to 2016
$1.5M
In Vivo Analysis of Viral CyclinR01CA103632 · NCI · UNIVERSITY OF COLORADO DENVER · PI VAN DYK, LINDA F. · 2004 to 2008
$1.4M
CHARACTERISTICS OF T-CELL RECEPTORSR37AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1992 to 2001
$522k
Characteristics of T Cell ReceptorsR56AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 2012 to 2012
$410k
Howard Hughes Medical InstituteNCI NIH HHS R01 CA103632NCI NIH HHS R01 CA168558NIAID NIH HHS AI074491NIAID NIH HHS AI-18785NIAID NIH HHS AI-22295NIAID NIH HHS P01 AI022295NIAID NIH HHS R01 AI018785NIAID NIH HHS R37 AI018785NIAID NIH HHS R56 AI018785NIAID NIH HHS T32 AI074491
6 · The paper itself

Abstract

IgG2a is known to be the most efficient antibody isotype for viral clearance. Here, we demonstrate a unique pathway of B-cell activation, leading to IgG2a production, and involving synergistic stimulation via B-cell antigen receptors, toll-like receptor 7 (TLR7), and IFNγ receptors on B cells. This synergistic stimulation leads to induction of T-box transcription factor T-bet expression in B cells, which, in turn, drives expression of CD11b and CD11c on B cells. T-bet/CD11b/CD11c positive B cells appear during antiviral responses and produce high titers of antiviral IgG2a antibodies that are critical for efficient viral clearance. The results thus demonstrate a previously unknown role for T-bet expression in B cells during viral infections. Moreover, the appearance of T-bet(+) B cells during antiviral responses and during autoimmunity suggests a possible link between these two processes.

Indexed as

AnimalsAutoimmunityB-LymphocytesDNA PrimersEnzyme-Linked Immunosorbent AssayFlow CytometryGammaherpesvirinaeHerpesviridae InfectionsImmunoglobulin GInterferon gamma ReceptorLymphocyte ActivationMembrane GlycoproteinsMiceMice, Inbred C57BLMice, KnockoutReal-Time Polymerase Chain ReactionDNA PrimersImmunoglobulin GInterferon gamma ReceptorMembrane GlycoproteinsReceptors, InterferonT-bet Transcription FactorT-Box Domain ProteinsTlr7 protein, mouseToll-Like Receptor 7interferon gammavirus

Identifiers

PMID23922396
PMCPMC3752276
OpenAlexW2089017798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.